Suppr超能文献

异基因造血干细胞移植后,参与慢性移植物抗宿主病发生的Foxp3 + T细胞亚群减少。

Reduction of Foxp3+ T cell subsets involved in incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

作者信息

Hu Yongxian, Cui Qu, Ye Yishan, Luo Yi, Tan Yamin, Shi Jimin, Huang He

机构信息

Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Department of Hematology, Beijing Tiantan Hospital, Capital Medical University, Dongcheng District, Beijing, China.

出版信息

Hematol Oncol. 2017 Mar;35(1):118-124. doi: 10.1002/hon.2255. Epub 2015 Oct 6.

Abstract

Foxp3+ T cells (CD4+ Tregs and CD8+ Treg) have been demonstrated to play roles in the maintenance of tolerance after allogeneic hematopoietic stem cell transplantation (Allo-HSCT). We have found that Foxp3+ γδTCR+ Treg cells (γδTregs) exerted regulatory functions. In the current study, patients were recruited and divided as non-cGVHD, limited cGVHD and extensive cGVHD groups. Healthy volunteers were recruited as healthy group. Treg cells were evaluated by flow cytometry. Serum cytokine levels of IL-2, tumour necrosis factor-α, interferon-γ and transforming growth factor-β1 (TGF-β1) were evaluated by ELISA. The results showed that percentages of CD4+ Tregs, CD8+ Tregs and γδTregs were all significantly increased in non-cGVHD group compared with those in healthy group, limited cGVHD group and extensive cGVHD group. Moreover, compared with extensive cGVHD group, percentages of these three types of Tregs were significantly increased in limited cGVHD group. The levels of TGF-β1 increased dramatically in non-cGVHD group compared with other groups. Spearman's correlation analysis revealed that the increased levels of TGF-β1 and IL-2 were positively associated with increased Treg subsets, indicating that TGF-β1 and IL-2 participated in the expansion process of Foxp3+ Tregs in vivo. Our findings support that increasing the number of Tregs following allo-HSCT would be a preferential strategy for controlling cGVHD. Copyright © 2015 John Wiley & Sons, Ltd.

摘要

Foxp3+ T细胞(CD4+调节性T细胞和CD8+调节性T细胞)已被证明在异基因造血干细胞移植(Allo-HSCT)后维持免疫耐受中发挥作用。我们发现Foxp3+γδTCR+调节性T细胞(γδ调节性T细胞)具有调节功能。在本研究中,招募患者并分为非慢性移植物抗宿主病(cGVHD)组、局限性cGVHD组和广泛性cGVHD组。招募健康志愿者作为健康组。通过流式细胞术评估调节性T细胞。通过酶联免疫吸附测定(ELISA)评估血清白细胞介素-2(IL-2)、肿瘤坏死因子-α、干扰素-γ和转化生长因子-β1(TGF-β1)的细胞因子水平。结果显示,与健康组、局限性cGVHD组和广泛性cGVHD组相比,非cGVHD组中CD4+调节性T细胞、CD8+调节性T细胞和γδ调节性T细胞的百分比均显著增加。此外,与广泛性cGVHD组相比,局限性cGVHD组中这三种类型调节性T细胞的百分比显著增加。与其他组相比,非cGVHD组中TGF-β1水平显著升高。Spearman相关性分析显示,TGF-β1和IL-2水平升高与调节性T细胞亚群增加呈正相关,表明TGF-β1和IL-2参与了体内Foxp3+调节性T细胞的扩增过程。我们的研究结果支持,异基因造血干细胞移植后增加调节性T细胞数量将是控制慢性移植物抗宿主病的优先策略。版权所有© 2015约翰威立父子有限公司。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验